| Dihydrolipoamide S-Acetyltransferase | |
|---|---|
| Protein Name | E2 (DLAT) |
| Gene | DLAT |
| UniProt ID | P10515 |
| PDB ID | 1QAA, 2D1J, 3l1c |
| Molecular Weight | 70 kDa (670 amino acids) |
| Subcellular Localization | Mitochondrial matrix |
| Protein Family | 2-oxoacid dehydrogenase complex family |
| Enzyme Commission | EC 2.3.1.12 |
Dihydrolipoamide S-Acetyltransferase (DLAT, also known as E2 component) is the catalytic core enzyme of the pyruvate dehydrogenase complex (PDC), one of the most important metabolic enzyme complexes in cellular metabolism. DLAT catalyzes the transfer of the acetyl group from acetyl-dihydrolipoamide to coenzyme A (CoA), forming acetyl-CoA and regenerating dihydrolipoamide. This reaction is a critical step linking glycolysis to the citric acid cycle (TCA cycle), making DLAT essential for cellular energy production through oxidative phosphorylation.
The pyruvate dehydrogenase complex is a large multienzyme assembly consisting of multiple copies of three enzymatic components: E1 (pyruvate dehydrogenase, encoded by PDHA1/PDHA2), E2 (DLAT), and E3 (dihydrolipoamide dehydrogenase, encoded by DLD). DLAT forms the structural and catalytic core of this complex, organizing the other components into a precise supramolecular structure that ensures efficient substrate channeling and metabolic regulation.
DLAT adopts a distinctive cubic symmetry, forming a 24-mer core structure that represents one of the largest known enzymatic assemblies in cellular metabolism. The protein consists of three distinct domains connected by flexible linker regions:
N-terminal lipoyl domain (~80 amino acids): Contains a lipoic acid cofactor covalently attached to a specific lysine residue. This domain undergoes large-scale conformational movements to shuttle the acetyl group between the active sites of E1 and E3.
Binding domain (~60 amino acids): Mediates interactions with E1 and E3 components, facilitating substrate channeling through the complex.
C-terminal catalytic domain (~400 amino acids): Contains the active site where acetyl transfer to CoA occurs. This domain forms the vertices of the cubic core structure.
The catalytic mechanism of DLAT involves a ping-pong bi-bi ordered ternary complex mechanism:
Acetylation step: The lipoyl arm of DLAT, bearing the acetyl group from E1, approaches the active site. The acetyl group is transferred to a conserved serine-threonine-lysine catalytic triad.
CoA binding: CoA enters the active site and binds to a specific pocket formed by the catalytic domain.
Acetyl transfer: The acetyl group is transferred from the acetylated enzyme intermediate to CoA, forming acetyl-CoA.
Product release: Acetyl-CoA is released, and the reduced lipoyl domain returns to accept another acetyl group from E1.
The 24-mer structure allows multiple simultaneous reactions, dramatically increasing the overall throughput of the complex. Each vertex of the cube can catalyze the reaction independently, providing a remarkable example of evolutionary optimization of metabolic efficiency.
DLAT is essential for aerobic energy metabolism in all eukaryotes and many prokaryotes. The pyruvate dehydrogenase complex sits at the crossroads of carbohydrate metabolism, converting pyruvate (the end product of glycolysis) into acetyl-CoA, the fuel for the TCA cycle. This conversion is irreversible and represents a major regulatory point in cellular metabolism.
Key metabolic functions include:
DLAT activity is tightly regulated through multiple mechanisms:
Phosphorylation/dephosphorylation: The E1 component (PDH) is regulated by phosphorylation (inactivating) at serine residues and dephosphorylation (activating) by PDH phosphatase. This is the primary regulatory mechanism.
Product inhibition: High concentrations of acetyl-CoA and NADH inhibit PDH activity, providing feedback regulation.
Energy status: High ATP/ADP and NADH/NAD+ ratios signal abundant energy and inhibit PDH.
Allosteric regulation: PDH is activated by high concentrations of pyruvate, ADP, and NAD+.
Transcriptional regulation: PDH expression is regulated by nutritional status, hormones (insulin, glucagon, thyroid hormone), and developmental programs.
DLAT has emerged as a significant player in Alzheimer's disease (AD) pathogenesis:
Metabolic dysfunction: Multiple studies have documented reduced DLAT expression and activity in AD brain tissue, particularly in the hippocampus and cerebral cortex. This reduction contributes to cerebral glucose hypometabolism, a hallmark of AD that precedes clinical symptoms by decades.
Mechanisms linking DLAT to AD:
Therapeutic implications:
DLAT alterations are also relevant to Parkinson's disease (PD):
DLAT and other PDC components have been studied as biomarkers:
Several therapeutic strategies target DLAT/PDH:
DLAT (dihydrolipoamide S-acetyltransferase) is the catalytic core of the pyruvate dehydrogenase complex, essential for converting pyruvate to acetyl-CoA and linking glycolysis to oxidative metabolism. In neurodegenerative diseases, particularly Alzheimer's disease, DLAT dysfunction contributes to cerebral hypometabolism and neuronal loss. Understanding DLAT regulation and developing therapeutic strategies to maintain its function represents an important frontier in treating neurodegenerative conditions characterized by metabolic deficits.